Muscular system protein myostatin London - Arabstoday The study of muscular system protein myostatin has been of great interest to researchers as a potential therapeutic target for people with muscular disorders. Although much is known about how myostatin affects muscle growth, there has been disagreement about what types of muscle cells it acts upon. New research from a team including Carnegie's Chen-Ming Fan and Christoph Lepper narrows down the field to one likely type of cell. Their work is published the week of August 6 by Proceedings of the National Academy of Sciences. Myostatin is known to inhibit muscle growth and its function is common in many mammals, including cows, sheep, dogs, humans, and mice. Mutant mice lacking in myostatin have muscle mass that is almost double that of normal mice. This property is what makes it an attractive potential drug target. By inhibiting myostatin a drug could, in theory, promote muscle growth, even in a person with a muscular disease. There has been considerable debate about which types of muscle cells are targeted by myostatin: fibrous muscle cells called myofibers, or muscle stem cells called satellite cells. The satellite cells are activated by muscular injury, begin to divide, and fuse to myofibers. Some studies seem to indicate myostatin targets satellite cells, others indicate myofibers. The research team, co-led by Fan and Se-Jin Lee, who is a former Carnegie Staff Associate and currently at Johns Hopkins University Medical School, used a variety of techniques -- both genetic and pharmacological -- and determined that the muscle growth caused by inhibiting myostatin does not significantly involve the incorporation of satellite cells into myofibers. This finding has major implications for the possible use of myostatin as a clinical target. There are outstanding questions about how a drug designed to target myostatin would work in clinical conditions in which patient's satellite cells are depleted. For example, in diseases like muscular dystrophy, satellite cells are believed to compensate for degenerated muscle cells in the early stages of the disease, causing the pool of these stem cells to shrink over time. This work raises the possibility that these patients might still benefit from myostatin inhibitors. "More work is needed to determine whether these findings are applicable to various clinical conditions, such as exercise, injury, and sarcopenia -- degenerative loss of muscle mass associated with aging," Fan said. "However, our findings initially indicate that many different diseases affecting the muscular system could potentially be responsive to drugs that inhibit myostatin and thus promote muscle growth, without regard to the status of the muscle stem cell pool." The other co-authors on the study are Than Huynh, Yun-Sil Lee, and Suzanne Sebald of the Johns Hopkins University School of Medicine; Sarah Wilcox-Adelman of the Boston Biomedical Research Institute; Naoki Iwamori and Martin Matzuk of Baylor College of Medicine. From sciencedaily
GMT 12:06 2018 Thursday ,13 December
Blue light in smartphones linked to blindness and some cancersGMT 11:56 2018 Friday ,30 November
Congo Ebola outbreak becomes second-worst in history, IRC saysGMT 17:52 2018 Sunday ,25 November
Russian medical team provides services to citizen in Talbiseh town in HomsGMT 11:26 2018 Thursday ,15 November
Cameroon strives to curb maternal and infant mortality in restive Anglophone regionsGMT 10:39 2018 Tuesday ,13 November
Emirati tourists warned against vaping, import of e-cigarettes into ThailandGMT 12:11 2018 Friday ,09 November
Conjoined Bhutanese twins separated by surgeons in AustraliaGMT 16:06 2018 Tuesday ,06 November
Drug-resistant bugs claim 33,000 lives a year in EuropeGMT 17:43 2018 Friday ,02 November
Study confirms cell phone radiation linked to cancer risks in male ratsMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor